Overall survival (OS) analysis from TCGA and CGGA datasets in low-grade gliomas showed that KYNU expression correlated with poor prognosis (p < 0.0001) (Figure 5A,B); that is, the higher the expression of KYNU, the lower the probability of survival. This evidence concerns the gene KYNU and central nervous system cancer.